X0306 4/A 2022-03-11 2022-03-15 0000748592 Brooklyn ImmunoTherapeutics, Inc. BTX 0001618457 Gurrola Sandra M C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220 true Vice President of Finance Stock Option (Right to buy) 1.93 2022-03-11 4 A 0 114500 0 A 2032-03-11 Common Stock 114500 114500 D The options vest and become exercisable in 36 substantially equal monthly installments from the grant date. This Form 4/A amends and restates the original Form 4 filed by the reporting person on March 15, 2022 (the "Original Form 4"). The Original Form 4 reported incorrect vesting terms. /s/ Sandra Gurrola 2022-03-17